Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Ono Pharmaceutical Co., Ltd. (4528.T)

Tokyo - Tokyo Delayed Price. Currency in JPY
Add to watchlist
2,459.50+33.50 (+1.38%)
At close: 3:15PM JST
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in JPY

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 10/23/2021
Current
Market Cap (intraday) 5
N/A
Enterprise Value 3
N/A
Trailing P/E
N/A
Forward P/E 1
N/A
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
N/A
Enterprise Value/Revenue 3
N/A
Enterprise Value/EBITDA 7
N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 0.42
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 33,358.00
52 Week Low 32,383.00
50-Day Moving Average 32,564.08
200-Day Moving Average 32,579.81

Share Statistics

Avg Vol (3 month) 3952.25k
Avg Vol (10 day) 3858.21k
Shares Outstanding 5499.14M
Implied Shares Outstanding 6N/A
Float 8364.57M
% Held by Insiders 117.92%
% Held by Institutions 138.91%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 456
Forward Annual Dividend Yield 42.23%
Trailing Annual Dividend Rate 350.00
Trailing Annual Dividend Yield 32.06%
5 Year Average Dividend Yield 41.67
Payout Ratio 428.80%
Dividend Date 3N/A
Ex-Dividend Date 4Sep 29, 2021
Last Split Factor 25:1
Last Split Date 3Mar 29, 2016

Financial Highlights

Fiscal Year

Fiscal Year Ends Mar 31, 2021
Most Recent Quarter (mrq)Jun 30, 2021

Profitability

Profit Margin 24.24%
Operating Margin (ttm)31.54%

Management Effectiveness

Return on Assets (ttm)8.92%
Return on Equity (ttm)12.60%

Income Statement

Revenue (ttm)321.73B
Revenue Per Share (ttm)644.57
Quarterly Revenue Growth (yoy)16.60%
Gross Profit (ttm)223.71B
EBITDA 117.76B
Net Income Avi to Common (ttm)78B
Diluted EPS (ttm)151.09
Quarterly Earnings Growth (yoy)12.00%

Balance Sheet

Total Cash (mrq)92.14B
Total Cash Per Share (mrq)184.6
Total Debt (mrq)8.85B
Total Debt/Equity (mrq)1.36
Current Ratio (mrq)3.01
Book Value Per Share (mrq)1,273.28

Cash Flow Statement

Operating Cash Flow (ttm)70.32B
Levered Free Cash Flow (ttm)36.75B
Advertisement
Advertisement